Valuation: Boston Scientific Corporation

Capitalization 131B 124B 115B 102B 185B 11,096B 202B 1,425B 526B 4,553B 491B 480B 19,749B P/E ratio 2024 *
66.6x
P/E ratio 2025 * 46.9x
Enterprise value 138B 130B 121B 108B 195B 11,687B 213B 1,501B 554B 4,796B 517B 506B 20,802B EV / Sales 2024 *
8.31x
EV / Sales 2025 * 7.23x
Free-Float
-
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.50%
1 week-2.14%
Current month-2.14%
1 month+0.53%
3 months+8.73%
6 months+15.06%
Current year+53.47%
More quotes
1 week
88.51
Extreme 88.513
91.31
1 month
86.01
Extreme 86.01
91.93
Current year
57.11
Extreme 57.11
91.93
1 year
54.86
Extreme 54.86
91.93
3 years
34.98
Extreme 34.98
91.93
5 years
24.10
Extreme 24.1
91.93
10 years
12.56
Extreme 12.56
91.93
More quotes
Director TitleAgeSince
Chief Executive Officer 59 2011-10-31
Director of Finance/CFO 58 2013-12-30
Chief Tech/Sci/R&D Officer 51 2020-06-30
Manager TitleAgeSince
Director/Board Member 59 2009-03-31
Chairman 59 2016-05-02
Director/Board Member 72 2014-02-28
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.50%-2.14%+61.46%+112.96%133B
+1.49%+1.43%+9.69%-15.81%202B
-2.10%-0.58%+73.59%+58.12%196B
+2.52%-1.58%+8.47%-25.88%166B
+1.79%+2.03%-0.72%-21.64%60.84B
-1.13%-0.25%-12.21%-26.78%43.72B
-0.88%-0.63%+2.49%-40.65%42.19B
+2.43%+4.37%+13.21%-7.88%40.09B
+0.81%-1.59%+19.53% - 37.12B
+1.39%-1.71%+50.28%-8.68%35.43B
Average +0.36%-0.65%+22.58%+2.64% 95.69B
Weighted average by Cap. +0.28%-0.59%+29.80%+15.29%
See all sector performances

Financials

2024 *2025 *
Net sales 16.58B 15.67B 14.54B 12.96B 23.41B 1,407B 25.65B 181B 66.72B 577B 62.26B 60.9B 2,504B 18.62B 17.6B 16.33B 14.56B 26.3B 1,580B 28.81B 203B 74.95B 648B 69.94B 68.41B 2,813B
Net income 1.98B 1.87B 1.73B 1.55B 2.79B 168B 3.06B 21.55B 7.95B 68.83B 7.42B 7.26B 299B 2.84B 2.69B 2.49B 2.22B 4.02B 241B 4.4B 30.99B 11.44B 98.99B 10.68B 10.44B 429B
Net Debt 6.98B 6.59B 6.12B 5.45B 9.85B 592B 10.79B 76.03B 28.07B 243B 26.19B 25.62B 1,054B 3.89B 3.68B 3.41B 3.04B 5.5B 330B 6.02B 42.44B 15.67B 136B 14.62B 14.3B 588B
More financial data * Estimated data
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Employees
48,000
More about the company
Date Price Change Volume
24-12-09 88.72 $ -1.50% 4,875,082
24-12-06 90.07 $ -0.51% 3,302,016
24-12-05 90.53 $ -0.34% 4,173,475
24-12-04 90.84 $ +0.41% 3,507,289
24-12-03 90.47 $ +0.04% 3,192,033

Delayed Quote Nyse, December 09, 2024 at 04:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A-
surperformance-ratings-light-chart BOSTON-SCIENTIFIC-CORPORAMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
88.72USD
Average target price
97.10USD
Spread / Average Target
+9.44%
Consensus

Quarterly revenue - Rate of surprise